All
Outcomes
Market
Price
AI Fair
Value
Value
Edge
Shai Gilgeous-Alexander
YesNo
Kevin Durant
YesNo
Cade Cunningham
YesNo
Stephen Curry
YesNo
Anthony Edwards
YesNo
Anthony Davis
YesNo
Tyrese Maxey
YesNo
Jamal Murray
YesNo
Jalen Brunson
YesNo
De'Aaron Fox
YesNo
Jimmy Butler
YesNo
Darius Garland
YesNo
James Harden
YesNo
Nikola Jokic
YesNo
Victor Wembanyama
YesNo
Donovan Mitchell
YesNo
Franz Wagner
YesNo
DeMar DeRozan
YesNo
Luka Doncic
YesNo
Paolo Banchero
YesNo
Ja Morant
YesNo
Pascal Siakam
YesNo
Jaylen Brown
YesNo
Joel Embiid
YesNo
Trae Young
YesNo
LaMelo Ball
YesNo
Devin Booker
YesNo
Desmond Bane
YesNo
Coby White
YesNo
Giannis Antetokounmpo
YesNo
AI Insights:
13 hours ago UpdatedFair Value Reasoning:
Shai Gilgeous-Alexander (75c) stands as the sole clear frontrunner. His main rival Tyrese Maxey is out for the regular season with a tendon injury (halting his clutch stats), and Anthony Edwards has just suffered a knee injury requiring 1-2 weeks off, putting him at severe risk of missing the '65-game' eligibility threshold (he has little margin for error). SGA recently hit a game-winner against Denver, cementing his 'Clutch' narrative, and sportsbooks have adjusted him to a heavy favorite at -340 (~77%). Cade Cunningham (5c) trails significantly in odds (+6000) despite decent stats. The crash in SGA's Polymarket price (45c) contradicts fundamentals and represents a significant market inefficiency.
Sign up to view more information
Movers
March 17, 2026 - March 18, 2026, Anthony Edwards' price crashed from 24.2c to 11.25c. The reason is the Timberwolves announced he will miss 1-2 weeks with right knee inflammation, putting him in serious danger of falling short of the NBA's 65-game minimum requirement for award eligibility.
March 17, 2026 - March 18, 2026, Shai Gilgeous-Alexander's price anomalously dropped from 65.3c to 45.8c, despite him hitting a game-winning clutch shot against the Nuggets on March 16. This drop is likely a panic sell-off due to low liquidity or a misinterpretation of the uncertainty caused by his rival's injury.
Divergence
There is a severe divergence between Polymarket and real-world odds. External data (Sportsbook Review, etc.) shows SGA has solidified a dominant lead (odds around -340) following rivals' injuries, implying a probability >75%. Conversely, SGA's price on Polymarket dropped to 46%, suggesting market participants have not updated their assessment of eligibility risks for rivals, or there is a severe liquidity pricing error.